Physician

Adam D Botwinick, M.D.

According to 2025 Medicare claims, Adam Botwinick, M.D. (NPI: 1366734097) practices ophthalmology in the Nassau County-Suffolk County, NY market, with the plurality of this provider's patient population coming from Nassau, NY. This provider's primary affiliated billing organization is OPHTHALMIC CONSULTANTS OF LONG ISLAND (NPI: 1285675660; TIN: 112498332) and primary practice location at 11554-1578. Botwinick is affiliated with the Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.

Botwinick's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 741 traditional Medicare patients, billed 2,719 HCPCS/CPT codes, and received $242,740 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,479 prescription claims across 1,030 beneficiaries totaling $643,023 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 39 records totaling $919. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $12,009 to $242,740. Similarly, Part D prescription costs have risen steadily, from $14,358 to $643,023. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$121K$243K2015 Medicare payment: $12,009 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $54,729 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $104,473 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $199,254 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $240,503 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $240,118 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $242,740 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157476$12,009
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019227643$54,729
20203931,352$104,473
20216282,329$199,254
20227362,607$240,503
20237432,710$240,118
20247412,719$242,740

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$341K$683K2015 Drug cost: $14,358 (USD; Tot_Drug_Cst)2016 Drug cost: $107,162 (USD; Tot_Drug_Cst)2017 Drug cost: $52,463 (USD; Tot_Drug_Cst)2018 Drug cost: $48,444 (USD; Tot_Drug_Cst)2019 Drug cost: $122,147 (USD; Tot_Drug_Cst)2020 Drug cost: $196,504 (USD; Tot_Drug_Cst)2021 Drug cost: $384,532 (USD; Tot_Drug_Cst)2022 Drug cost: $530,171 (USD; Tot_Drug_Cst)2023 Drug cost: $682,549 (USD; Tot_Drug_Cst)2024 Drug cost: $643,023 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201587214$14,358
20163021,330$107,162
2017251799$52,463
2018218866$48,444
20192931,404$122,147
20203641,119$196,504
20215772,366$384,532
20228163,744$530,171
20239594,662$682,549
20241,0305,479$643,023

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more233314$105
92014Established patient complete exam of visual system410433$101
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more389581$73
92083Exam of visual field with extended testing306388$54
92133Imaging of optic nerve367386$29

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost1469,233$90,205
RocklatanNetarsudil Mesylat/Latanoprost1357,212$89,156
RestasisCyclosporine453,135$64,987
RhopressaNetarsudil Mesylate1055,630$62,163
CombiganBrimonidine Tartrate/Timolol1135,869$43,503

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.39$919Oyster Point Pharma, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adam D. Botwinick, M.D.?

Tedicare shows public-source Medicare data for Adam D. Botwinick, M.D. (NPI 1366734097), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam D. Botwinick, M.D. have ACO affiliation data?

Adam D. Botwinick, M.D. is shown with ACO affiliation data for Vytalize Health 9 ACO LLC (REACH, ACO ID D0313).

What billing organization is linked to Adam D. Botwinick, M.D.?

Adam D. Botwinick, M.D. is linked to OPHTHALMIC CONSULTANTS OF LONG ISLAND (billing NPI 1285675660) in the available physician profile data.

Does Adam D. Botwinick, M.D. have Open Payments data?

Adam D. Botwinick, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.